Cited by 253Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994–1998: analysis of data from the general practice research database

Open access
Majeed, A, Moser, K, Carroll, K·2001·Heart

Abstract

OBJECTIVE: To determine the prevalence of atrial fibrillation in England and Wales, and examine trends in its treatment with warfarin and aspirin between 1994 and 1998. DESIGN: Analysis of data from the general practice research database. SETTING: England and Wales. PATIENTS: 1.4 million patients registered with 211 general practices. MAIN OUTCOME MEASURES: Age and sex specific prevalence rates of atrial fibrillation; percentage of patients with atrial fibrillation treated with oral anticoagulants or aspirin. RESULTS: The prevalence of atrial fibrillation in 1998 was 12.1/1000 in men and 12.7/1000 in women. Prevalence increased from less than 1/1000 in under 35 year olds to over 100/1000 in those aged 85 years and over. There was a 22% increase in the age standardised prevalence of atrial fibrillation in men and a 14% increase in women between 1994 and 1998. The percentage of patients prescribed oral anticoagulants increased from 20% to 34% in men and from 17% to 25% in women. The percentage of men with atrial fibrillation prescribed aspirin increased from 26% to 36%, and the percentage of women increased from 24% to 36%. Applying the age and sex specific prevalence and treatment rates to the population gives an estimate of around 650 000 cases of atrial fibrillation in England and Wales. The greatest number of cases occurs in the 75–84 year old age group. CONCLUSIONS: The number of patients in the community with identified atrial fibrillation is increasing. There has also been a pronounced increase in the percentage of patients with atrial fibrillation prescribed oral anticoagulants or aspirin.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/heart.86.3.284

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Atrial Fibrillation Investigators. Risk factors for stroke and eYcacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994;154:1449-57.
  2. Carroll K, Majeed A. Trends in mortality and hospital admissions associated with atrial fibrillation in England and Wales. Health Stat Q 2001;9:37-43.
  3. Sudlow CM, Rodgers H, Kenny RA, et al. Service provision and use of anticoagulants in atrial fibrillation. BMJ 1995;311:558-60.

Cited by

Sorted by citations

Authors
Majeed, A., Moser, K., & Carroll, K.
Affiliations
University College London (GB)
Corresponding author
Majeed, A
Venue
Heart
Publisher
BMJ
Published
2001-09-01
Volume
86
Issue
3
Pages
284-288
ISSN
  • 1355-6037 (ISSN-L)
  • 1468-201X
OpenAlex
W1979263051
Cited by
253
References
21
Citations by year
2025: 3 · 2024: 3 · 2023: 3 · 2022: 9 · 2021: 4 · 2020: 10 · 2019: 10 · 2018: 11 · 2017: 9 · 2016: 14 · 2015: 9 · 2014: 20 · 2013: 18 · 2012: 30
FWCI
3.65
Type
journal article
Language
en
Open access
Locations
  • Heart (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords
atrial fibrillation, prevalence trends, warfarin, aspirin, oral anticoagulants, anticoagulant prescribing, general practice, primary care, sex differences, age differences, England and Wales
MeSH terms
Administration, Oral, Adolescent, Adult, Aged, Aged, 80 and over, Anticoagulants, Aspirin, Atrial Fibrillation, Child, Child, Preschool, England, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Platelet Aggregation Inhibitors, Wales, Warfarin, Prevalence, Age Distribution, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review